AstraZeneca’s DKD pipeline highlights potential to differentiate in kidney disease space: GlobalData Read more
AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023 Read more
AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 bn sales by 2029: GlobalData Read more
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData Read more
Blockbuster Enhertu may get tumor agnostic label, targeting any HER2-expressing cancer: GlobalData Read more
Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData Read more